top of page

News & Media
Florida Angels Join $4.7M Hyperspectral Imaging Round, AI Writes up to One-Third of Microsoft's Code, and Why Clarity is Kindness
Coologics | Drug-free vaginal infection treatment Participating Groups: Ohio State Early Investor Network , Illini Angels Coologics is developing a drug-free intravaginal cooling device called Vlisse to treat vaginal infections without antibiotics. The Cleveland-based clinical-stage medical device company recently secured $3M in Seed funding led by Prevail and Dream Ventures, with participation from Ohio State Early Investor Network and Illini Angels. Funds will be used to a
grdirks
May 1, 20251 min read
Coologics Secures $3M for Drug-Free Vaginal Infection Treatment Device
Coologics , a US-based clinical-stage medical device company, has successfully closed an oversubscribed seed funding round, raising over $3 million for its innovative vaginal infection treatment device, Vlisse. Read more.
grdirks
Apr 24, 20251 min read
Cleveland women's healthtech startup secures $3M, doubling initial target
A Cleveland-based clinical-stage medical device company announced it has closed an oversubscribed $3 million seed funding round, doubling the initial $1.5 million target. Read more.
grdirks
Apr 24, 20251 min read
COOLOGICS Initiates Multi-Center Clinical Trials for Vlisse
COOLOGICS , a clinical-stage medical device company, has announced the commencement of new, larger multi-center, open-label clinical trials for its innovative product, Vlisse. These trials will begin this month with the objective of gathering sufficient data to secure FDA clearance for the device. Read more.
grdirks
Apr 11, 20251 min read
COOLOGICS Initiates Multi-Center Clinical Trials for Vlisse
COOLOGICS is launching multi-center clinical trials for its intravaginal cooling device to provide drug-free treatment for vaginal yeast infections and potentially reduce the risk of preterm births. Read more.
grdirks
Apr 11, 20251 min read
COOLOGICS Initiates Multi-Center Clinical Trials for Vlisse
COOLOGICS , a clinical-stage medical device company, has announced the commencement of new, larger multi-center, open-label clinical trials for its innovative product, Vlisse. These trials will begin this month with the objective of gathering sufficient data to secure FDA clearance for the device. The site initiation visits are already scheduled, during which participating centers will receive comprehensive protocol training to ensure immediate enrollment and adherence to stu
grdirks
Apr 10, 20251 min read
COOLOGICS Launches Multi-Center Trials for Novel Cooling Device to Treat Vaginal Yeast Infections
COOLOGICSSearch company, a Cleveland-based clinical-stage medical device company, announced this month the initiation of multi-center, open-label clinical trials for VlisseSearch drug, its innovative intravaginal cooling device designed to treat vulvovaginal candidiasis (VVC)Search disease, commonly known as yeast infectionsSearch disease. Read more.
grdirks
Apr 10, 20251 min read
Vlisse™ is a Class I Device in the European Union CE Mark Pending and a FDA Class II device pending FDA clearance.
bottom of page

.png)
